Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : GUMM - Eliminate the Common Cold -- Ignore unavailable to you. Want to Upgrade?

To: Pete Mason who wrote (942)	9/20/1999 9:54:00 PM
From: Mike M	Read Replies (1) \| Respond to of 5582

Hey, Pete, since you don't have a job I guess you can just sit here and talk on the thread all day and night long to yourself...Thanks for the first stupid post.... Looking forward to the rest....actually, I probably won't read that many, but I will promise to pay enough attention to post at least two on the dog pound for each of yours. My guess is that Dan and Howard will too... Hey we can screw up two threads this way... regards, Mike

To: Pete Mason who wrote (942)	9/21/1999 5:02:00 PM
From: Mad2	Read Replies (2) \| Respond to of 5582

Pete, Anyone seriously interested in GUMM should compare to QGLY. At least if they think they are making a long term investment. GUMM is afloat based on dreams and hype with a enterprise value of 11.78/share (share price less cash times) or 88mil. A company without a proven product or market valued at 88 mil or 8 times that of a company with sound finances (25 mil cash) and a demonstrated track record. Do you think a lozenge or a nose spray that does the same thing will be easier to sell in the market? Admittedly I'm not suggesting QGLY has a great track record, in fact I'd be supprised if GUMM's is as good given GUMM has no cash to speak of to develope ZICAM. Amazingly this company with claims/products very similar to GUMM closed today at 3 1/4 with a market cap of 39 mil (mind you QGLY has 28 mil in cash and no debit) for a enterpirse value of 11 mil dollars. This is a outfit with a book value of 3.5/share or .25/share more that the market cap. With 36 mil in sales last year what's wrong with this picture.....Well despite having the only zinc lozenge to reduce the duration of the common cold in a double blind study and being the leading pharmacist recomended cold remedy they have to create brand awareness and fight off the me too sellers. Quite a battle for a small outfit. The Company's television campaign will also be expanded in October, when two :30 spots highlighting the Company's Cold-EEZE lozenge and Bubblegum products appear on CNN, NBC in the nation's top five markets and in selected markets on CBS. To further reinforce the campaign, the nation's top-ranked syndicated programming will also begin airing :10 and :30 second ads this fall. ''We are committed to letting consumers know that COLD-EEZE is the nation's leading pharmacist-recommended cold remedy of its kind,'' says Guy Quigley, CEO of the Company. ''In addition, to our TV and radio efforts, we will also begin a print campaign in November that will run through February 2000. It is our ongoing goal to increase the awareness for COLD-EEZE, while continually distancing ourselves from the battery of unproven and medically-ineffective imitators capitalizing on our advertising.'' biz.yahoo.com The Quigley Corporation, a natural health and homeopathic drug company, is the maker of COLD-EEZE®, and COLD-EEZE® homeopathic bubble gum, Sugar-free COLD-EEZE® and the BodyMate(TM) Nutrition and Weight Management Program. COLD-EEZE® is the only zinc gluconate glycine (ZIGG)(TM) lozenge proven in two double-blind studies to reduce the duration and severity of common cold symptoms. biz.yahoo.com Additionally QGLY is expanding their distribution DOYLESTOWN, Pa., Sept. 10 /PRNewswire/ -- The Quigley Corporation (Nasdaq: QGLY - news) announced today that 7-11, Inc. stores nationwide and W.H. Smith, a national chain that services over 257 major hotels and maintains shops in 100 domestic airports, will begin displaying new COLD-EEZE® ''Travel Pack'' display configurations this fall. The new counter display holds 12 ''Travel Pack'' bags containing a one day supply of six, mixed-flavor COLD-EEZE lozenges in colorful, purse-sized packaging emblazoned with the clearly- identifiable COLD-EEZE logo. biz.yahoo.com COLD-EEZE (R) to Expand Distribution Worldwide The Quigley Corporation Establishes Communications With the Pharmaceutical Representatives of 49 Nations biz.yahoo.com